ESMO 2019 | NEPA to prevent chemotherapy-induced nausea and vomiting

Name: NEPA to prevent chemotherapy-induced nausea and vomiting
Uploaded: 2019-09-28T00:00:00Z
Duration: 2 min 15 s
Description: Matti Aapro, MD, of Genolier Cancer Center, Genolier, Switzerland, outlines the efficacy of intravenous NEPA for the prevention of CINV following cisplatin and AC chemotherapy and whether is it a viable prevention treatment. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Matti Aapro • 28 Sep 2019

ESMO 2019

General

Matti Aapro, MD, of Genolier Cancer Center, Genolier, Switzerland, outlines the efficacy of intravenous NEPA for the prevention of CINV following cisplatin and AC chemotherapy and whether is it a viable prevention treatment. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.